Kenneth C. Frazier

Chairman, President & Chief Executive Officer, Merck & Co., Inc.

Kenneth C. Frazier is chairman, president, and chief executive officer of Merck & Co., Inc., effective December 1, 2011.

Previously, Ken served as president of Merck with responsibility for leading Merck's three major divisions: Global Human Health, Merck's sales and marketing division for pharmaceutical and vaccine products; Merck Manufacturing Division, Merck's manufacturing and supply division; and Merck Research Laboratories, Merck's research organization.

Ken joined Merck in 1992 as vice president, general counsel and secretary of the Astra Merck Group. He was elected vice president of Public Affairs in 1994, and, in 1997, assumed the additional responsibilities of assistant general counsel, corporate staff. Ken was promoted to vice president and deputy general counsel in January 1999. In December 1999, he became senior vice president and general counsel. In this role, he oversaw Merck's legal and public affairs functions and The Merck Company Foundation. In November 2006, he was promoted to executive vice president and general counsel. Ken served as executive vice president and president, Global Human Health, from 2007 to May 2010, when he became Merck president. In December 2011, Ken was elected the chairman of the board of directors.

Ken has made considerable contributions across Merck's business, leading several key transformation efforts for the company. Ken played a key role in the 2009 merger of Merck and Schering-Plough and maintained solid sales momentum throughout the post-merger integration period. Under Ken's leadership, Merck has driven the growth of key products, expanded their global reach, launched new products, and advanced a robust-late-stage research and development pipeline. Ken also implemented an innovative new global commercial sales model, dramatically improved the cost structure and redeployed resources into high-growth emerging markets.

Prior to joining Merck, Ken was a partner with the Philadelphia law firm of Drinker Biddle & Reath, and his significant contributions in the legal area have earned broad recognition. Ken has been honored for his advocacy in providing legal representation to low-income communities and for his personal pro bono work, including his successful defense of a death row inmate, by the Equal Justice Initiative (2009), the National Legal Aid & Defender Association (2008 Exemplar Award), and the Pro Bono Institute housed at Georgetown University Law Center (2003 Laurie D. Zelon Award). In 2004, the Association of Corporate Counsel presented Ken with its Excellence in Corporate Practice Award, which recognizes achievements in legal advocacy and counseling, service to the legal profession, public service and civic and community contributions.

Ken was awarded the Philadelphia Bowl in 2011 for outstanding leadership and commitment to advancing the interests of the city of Philadelphia. He also received the Distinguished Alumni Award in 2003 from The Pennsylvania State University, the highest honor the university bestows on graduates whose professional achievements, personal qualities and community involvement exemplify the goals of Penn State. In 2001, Ken also received the Alumni Fellow Award from The Pennsylvania State University, the most prestigious award given by the Alumni Association to those recognized as leaders in their professional fields who are committed to sharing their knowledge and expertise with the university community.

Ken sits on the boards of Exxon Mobil Corporation and Cornerstone Christian Academy in Philadelphia, PA. Ken also is a member of the Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association.

Ken received his bachelor's degree from The Pennsylvania State University and holds a J.D. from Harvard Law School.

He was elected to the Board of Trustees as a business and industry trustee for a three-year term beginning July 1, 2009.

December 2011